A pilot approach of pharmacokinetically guided 5-fluorouracil (5-FU) dosing for personalized gastric cancer treatment.

Eduardo Castanon Alvarez,Azucena Aldaz,Amaia EgÃÂ¼es,Patricia Martin,Juan Pablo Fusco,Leire Zubiri,Lucia Ceniceros,A. Chopitea,Jose Luis HernÃÂ¡ndez-Lizoain,Javier Rodríguez

A pilot approach of pharmacokinetically guided 5-fluorouracil (5-FU) dosing for personalized gastric cancer treatment.

2015

Eduardo Castanon Alvarez
Azucena Aldaz
Amaia EgÃÂ¼es
Patricia Martin
Juan Pablo Fusco
Leire Zubiri
Lucia Ceniceros
A. Chopitea
Jose Luis HernÃÂ¡ndez-Lizoain
Javier Rodríguez

e13587 Background: Infusional 5FU schedules remain the backbone of conventional regimens for gastric cancer (GC) patients (pts). 5-FU pharmacokinetic variability when posology is calculated by the ...

Keywords:

Cancer
Fluorouracil
Oncology
Dosing
Pathology
Internal medicine
Medicine
cancer treatment
Pharmacokinetics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations